OBM Geriatrics is an Open Access journal published quarterly online by LIDSEN Publishing Inc. The journal takes the premise that innovative approaches – including gene therapy, cell therapy, and epigenetic modulation – will result in clinical interventions that alter the fundamental pathology and the clinical course of age-related human diseases. We will give strong preference to papers that emphasize an alteration (or a potential alteration) in the fundamental disease course of Alzheimer’s disease, vascular aging diseases, osteoarthritis, osteoporosis, skin aging, immune senescence, and other age-related diseases.

Geriatric medicine is now entering a unique point in history, where the focus will no longer be on palliative, ameliorative, or social aspects of care for age-related disease, but will be capable of stopping, preventing, and reversing major disease constellations that have heretofore been entirely resistant to interventions based on “small molecular” pharmacological approaches. With the changing emphasis from genetic to epigenetic understandings of pathology (including telomere biology), with the use of gene delivery systems (including viral delivery systems), and with the use of cell-based therapies (including stem cell therapies), a fatalistic view of age-related disease is no longer a reasonable clinical default nor an appropriate clinical research paradigm.

Precedence will be given to papers describing fundamental interventions, including interventions that affect cell senescence, patterns of gene expression, telomere biology, stem cell biology, and other innovative, 21st century interventions, especially if the focus is on clinical applications, ongoing clinical trials, or animal trials preparatory to phase 1 human clinical trials.

Papers must be clear and concise, but detailed data is strongly encouraged. The journal publishes a variety of article types (Original Research, Review, Communication, Opinion, Comment, Conference Report, Technical Note, Book Review, etc.). There is no restriction on the length of the papers and we encourage scientists to publish their results in as much detail as possible.

Indexing: 
.

Publication Speed (median values for papers published in 2023): Submission to First Decision: 5.7 weeks; Submission to Acceptance: 17.9 weeks; Acceptance to Publication: 7 days (1-2 days of FREE language polishing included)

Current Issue: 2024  Archive: 2023 2022 2021 2020 2019 2018 2017
Open Access Interview

An Interview with Dr. Ines Testoni

OBM Geriatrics Editorial Office 

  1. LIDSEN Publishing Inc., 2000 Auburn Drive, One Chagrin Highlands, Suite 200, Beachwood, OH, USA

Received: June 25, 2023 | Accepted: June 26, 2023 | Published: June 27, 2023

OBM Geriatrics 2023, Volume 7, Issue 2, doi:10.21926/obm.geriatr.2302241

Recommended citation: OBM Geriatrics Editorial Office. An Interview with Dr. Ines Testoni. OBM Geriatrics 2023; 7(2): 241; doi:10.21926/obm.geriatr.2302241.

© 2023 by the authors. This is an open access article distributed under the conditions of the Creative Commons by Attribution License, which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is correctly cited.

Click to view original image

Dr. Ines Testoni

1. Could You Please Tell Us Your Scientific Background?

Ines Testoni, professor of social psychology, director of the Master in “Death Studies & The End of Life” and specialization in “Creative Arts Therapies for the Improvement of Resilience."

2. Can You Share Your Career Development Story Briefly? For Example, What Cases Have Influenced You the Most?

I am a psychologist, psychotherapist with training in classical Morenian psychodrama and systemic-relational therapy, and a philosopher. I work on the themes of death and dying, palliative care and support for the dying and the grieving, with art therapies.

3. Is There a Book You’ve Read that You'd Recommend Universally (i.e., to Everyone You Meet)?

One of the topics that interest me most is primary and secondary death education, i.e., in the first case addressed to those who do not have to face death directly, in the second case to those who do. In particular, I am interested on the one hand in enabling people to become aware of how much the terror of death influences our daily actions without us realising it. On the other hand, I am interested in helping those who suffer because they have to die or have a relative who has to die, so they reflect on what it means to die and understand that they do not know why they are suffering. It is important to offer these people the possibility of accessing the great contents that the history of humanity offers to each of us in order to face this passage well.

4. What Is Your Main Research Area? What Got You Interested in Scientific Research in the First Place?

A book that I recommend everyone to read and understand - accessible to anyone - is Emanuele Severino's 'Law and Chance' (Bloomsbury), because it allows us to understand the fundamentals of what we believe is reality.

5. Where Are Your Sources of Information? Where Do You Get Your Latest News about Geriatrics Research? Where Do You Take Inspiration From?

The psychological and political effects of the terror of death we must learn to gain control over.

6. What Is Your Long-Term Research Goal?

Applying these studies to the end of life in the geriatric age.

7. What Are the Recent Research Trends that You, as a Scholar, Would Suggest OBM Geriatrics Observe and Follow in the Coming Years?

The application of palliative care in geriatrics.

8. Do You Have Any Suggestions or Recommendations for Young Scientists, for instance, Your Students and Young Collaborators?

I advise young people and my students to study the field of death studies and palliative care well, because it is still a little explored and little practiced territory that will gain more and more interest in the future.

9. What Do You Think of the Future of OBM Geriatrics, an Open-Access Journal?

I think OBM Geriatrics needs to become more and more known in academic and clinical settings.

Newsletter
Download PDF Download Citation
0 0

TOP